# P1.14-61 EGFR Inhibitors Plus Bevacizumab Are Superior Compared to EGFR Inhibitor Monotherapy in Advanced EGFR+ NSCLC Patients with BIM Deletions

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/p1-14-61-egfr-inhibitors-plus-bevacizumab-are-superior-compared-to-egfr/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Andrés F. Cardona,Óscar Arrieta,Alejandro Ruíz-Patiño,Z.L. Zatarain Barrón,L. Rojas,Luis Corrales,Claudio Martín,Feliciano Barrón,Carolina Sotelo,J. Rodriguez,Luisa Ricaurte,Jenny Ávila,D. Mayorga,Pilar Archila,J. Otero,H. Freitas,Vladmir Cláudio Cordeiro de Lima,Luís Más,Hernán Carranza,C. Vargas,Rafael Rosell |
| Citations | 1 |
| DOI | 10.1016/j.jtho.2019.08.1212 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.jto.org/article/S1556086419318957/pdf |
| OpenAlex ID | https://openalex.org/W2982172552 |
| Type | article |
| Year | 2019 |

## Paper authors

- [L. Rojas](https://scholariq.org/researchers/l-rojas/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.